Pay in 4 interest-free payments of $7.42 Learn more
Ships within 48 hours · Estimated delivery Sep 24 - Sep 29
Health 3 , e190e191 (2015)
persistent, severe abdominal pain) Hypersensitivity to DPP-4 inhibitors in the past Pregnancy/breastfeeding Some DPP-4 inhibitors are contraindicated at certain thresholds of renal impairment (see Table 2 ) Some DPP-4 inhibitors are contraindicated in hepatic impairment (see Table 3 ) Type 1 diabetes Diabetic ketoacidosis Cautions History of pancreatitis Moderate heart failure (saxagliptin only, due to limited experience) Severe heart failure (saxagliptin and vildagliptin, due to limited experience) Some DPP-4 inhibitors are cautioned at certain thresholds of renal impairment, and dose reductions may be required (see Table 2 ) Drug interactions No significant interactions have been reported between DPP-4 inhibitors and any other drugs
PhilipsCAPandeAShasthrySMJamwalKDKhillanVChandelSSet al
A clinical review in Growth Hormone and IGF Research comparing GHRH analogs and ghrelin receptor agonists demonstrating the superior IGF-1 response from dual-pathway peptide combinations versus single-pathway protocols
US$ 20.82
US$ 26.70
US$ 23.09
